Publications


 

Conference proceedings

24. Vlachakis D, Nicolaides NC, Papageorgiou L, Charmandari E. Tracing the Glucocorticoid Receptor evolutionary pedigree; insights from a comprehensive phylogenetic analysis of the full NR super-family. 55th ESPE Meeting, Paris, France, 09/2016

23. Nicolaides NC, Skyrla E, Vlachakis D, Psarra AMG, Sertedaki A, Kossida S, Charmandari E. The Natural Mutant Receptor hGR [alpha] T556I Causes Primary Generalised Glucocorticoid Resistance Through Decreased Affinity for the Ligand and Impaired Interaction with the GRIP1 Coactivator. Hormone Research in Paediatrics Vol. 82 Supplement1. ESPE Abstracts (2015) 84 P-2-168

22. Vlachakis D, Bencurova E, Bhide M, Kossida S. Integrating bioinformatics tools to investigate protein phosphorylation. PeerJ PrePrints 2015, 3:e1130

21. Vlachakis D, Fakourelis P, Makris C, Kossida S. DrugOn: a fully integrated pharmacophore modeling and structure optimization toolkit. PeerJ PrePrints 2015, 2:e668v1

20. Nicolaides NC, Vlachakis D, Sertedaki A, Kossida S, Chrousos1 GP, Charmandari E. Functional characterization of a novel heterozygous point mutation in the human glucocorticoid receptor gene causing Primary Generalized Glucocorticoid Resistance. 53rd ESPE Meeting, Dublin, Ireland, 09/2014

19. Sertedaki A, Markou A, Kaltsas G, Androulakis I, Pappa T, Gouli A, Papanastasiou L, Zacharoulis A, Karavidas A, Ragkou D, Vlachakis D, Kossida S, Campanac E, Hoffman DA, De La Luz M, Xekouki P, Stratakis CA, Charmandari E, Chrousos GP, Piaditis GP. Mutations of the KCNJ5 Gene in Patients with Hypertension and Increased Aldosterone Response to ACTH. 95th Endocrine Society Annual Meeting, Chicago, IL, USA; 06/2014

18. Nicolaides NC, Geer EB, Vlachakis D, Sertedaki A, Bacopoulou I, Kossida S, Chrousos GP, Charmandari E. A novel point mutation of the human glucocorticoid receptor gene causes Primary Generalized Glucocorticoid Resistance through reduced flexibility of helix 10 of the ligand-binding domain of the receptor and decreased affinity for the ligand. 95th Endocrine Society Annual Meeting, Chicago, IL, USA; 06/2014

17. Vlachakis D, Armaos A, Kasampalidis I, Filntisi A, Kossida S. ASSP; the Antibody Secondary Structure Profile search tool. Proceedings of the 2nd International Conference on Algorithms for Big Data; 01/2014

16. Nicolaides NC, Vlachakis D, Sertedaki A, Kossida S, Chrousos GP, Charmandari E. A novel point mutation of the human glucocorticoid receptor gene causes Primary Generalized Glucocorticoid Resistance (Chrousos syndrome) through reduced flexibility of Helix 10 of the ligand-binding domain. 41st Hellenic Endocrine Society Meeting, Porto Cheli, Greece; 05/2014

15. Vlachakis D, Vlachakis C. Understanding of emotions and cardiovascular related diseases. PeerJ PrePrints 2014, 2:e761v1

14. Vlachakis D, Vlachakis C. Prevalence of disordered eating attitudes in young adults. PeerJ PrePrints. 2014, 2:e538v1

13. D Vlachakis, Kossida S. Introducing ADCD; the Antibody Drug Conjugate Designer suite. 7th Annual Proteins Congress; 2nd Annual Biosimilars & Biobetters Congress. London, UK, 3-4 April 2014

12. D Vlachakis, Tsiliki G, Kossida S. 3D Molecular Modelling of the Helicase Enzyme of the Endemic, Zoonotic Greek Goat Encephalitis Virus. 14th International Conference on Engineering Applications of Neural Networks, Halkidiki, Greece, 13-16 September 2013

11. Steinhauf D, Rodriguez A, D Vlachakis, Virgo G, Kristell C, Olsson I, Bongcam-Rudloff E, Kossida S, Bjerling P. Motifs in the Clr2 protein specific for mating-type silencing. Talk 73 & Poster 190. EMBO Conference on Fission Yeast: pombe 2013. 7th International Fission Yeast Meeting. London, United Kingdom, 24 - 29 June 2013

10. D Vlachakis, Koumandou VL, Kossida S. A holistic evolutionary and structural study of flaviviridae provides insights into the function and inhibition of HCV Helicase, 2013. EEBMB, 64th Conference in Athens.

9. D Vlachakis, Kossida S. Recipes to make the most out of your wetlab data in less than 10 minutes. AllBio Meeting. Milan, December 2012

8. Nikolopoulos G, D Vlachakis, Waltenspiel B, Warren W, Vlassi M. Preliminary structural characterization of DEFL, a good candidate for anticancer research. 33rd FEBS Congress, Molecular Machines, Athens, Greece, June-July 2008.

7. D Vlachakis, Sellis D, Tartas A, Nikolopoulos G, Economou I, Vlassi M. Evaluation of Molecular dynamics simulations using the known structural behaviour of a repeat containing protein. EEBE Conference, Thessaloniki, May 2008.

6. D Vlachakis, Tartas A, Vlassi M. Using molecular dynamics simulations to investigate the structural stability of a repeat containing protein. 32nd FEBS Congress, Molecular Machines, Vienna, Austria, July 2007

5. Nikolopoulos G, D Vlachakis, Waltenspiel B, Warren W, Vlassi M. Structure predictions, cloning and overexpression of DEFL, the product of a drosophila uncharacterized gene. 59th National Conference of the Hellenic Society of Biochemistry & Molecular Biology, Athens, December 2007.

4. Tartas A, D Vlachakis, Palaiomylitou M, Vlassi M. HelicosisMD: A Suite of computer programs for monitoring conformational changes during Molecular Dynamics simulations. 58th National Conference of the Hellenic Society of Biochemistry & Molecular Biology, Patras, November 2006.

3. D Vlachakis, Tartas A, Palaiomylitou M, Vlassi M. Using Molecular Dynamics Simulations to investigate the structural stability of the Tup1 Interaction Domain of the Transcriptional Regulator SSN6. 3rd Hellenic Crystallography Conference, Patras, October 2006.

2. Dragoumani K, D Vlachakis, Vlassi M. 3D–Modelling of the no-phosphorylating glyceraldehyde 3-Phasphate Dehydrogenase from S.Pyogenes. 3rd Hellenic Crystallography Conference, Patras, October 2006.

1. D Vlachakis, Muller-Quernheim J, Zissel G. CXCR3-Agonistic Chemokines in Interstitial Lung Diseases. 34thAnnual Meeting of the German Society of Immunology, Berlin, September 2003.


 
Top